FMP

FMP

Enter

ADVM - Adverum Biotechnolog...

Profile of Adverum Biotechnologies, Inc.(ADVM), Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product

photo-url-https://financialmodelingprep.com/image-stock/ADVM.png

Adverum Biotechnologies, Inc.

ADVM

NASDAQ

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

7.83 USD

-0.07 (-0.894%)

About

ceo

Dr. Laurent Fischer

sector

Healthcare

industry

Biotechnology

website

https://www.adverum.com

exchange

NASDAQ

Description

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

CIK

0001501756

ISIN

US00773U1088

CUSIP

00773U108

Address

800 Saginaw Drive

Phone

650 656 9323

Country

US

Employee

121

IPO Date

Jul 31, 2014

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep